Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Ab&B Biotech
company
About
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.
- 251 - 500
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $92.73M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$92.73M
Ab&B Biotech has raised a total of
$92.73M
in funding over 2 rounds. Their latest funding was raised on
Jul 16, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 16, 2021 | Series C | $92.73M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Ab&B Biotech is funded by 2 investors.
Sanhua Hongdao Investment
and Puxin Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
